IRIS Accounts Production v18.3.0.590 09294039 director 1.12.16 30.11.17 30.11.17 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure092940392016-11-30092940392017-11-30092940392016-12-012017-11-30092940392015-11-30092940392015-12-012016-11-30092940392016-11-3009294039ns15:EnglandWales2016-12-012017-11-3009294039ns14:PoundSterling2016-12-012017-11-3009294039ns10:Director12016-12-012017-11-3009294039ns10:PrivateLimitedCompanyLtd2016-12-012017-11-3009294039ns10:SmallEntities2016-12-012017-11-3009294039ns10:AuditExempt-NoAccountantsReport2016-12-012017-11-3009294039ns10:SmallCompaniesRegimeForDirectorsReport2016-12-012017-11-3009294039ns10:SmallCompaniesRegimeForAccounts2016-12-012017-11-3009294039ns10:FullAccounts2016-12-012017-11-3009294039ns10:OrdinaryShareClass12016-12-012017-11-3009294039ns10:RegisteredOffice2016-12-012017-11-3009294039ns5:CurrentFinancialInstruments2017-11-3009294039ns5:CurrentFinancialInstruments2016-11-3009294039ns5:ShareCapital2017-11-3009294039ns5:ShareCapital2016-11-3009294039ns5:RetainedEarningsAccumulatedLosses2017-11-3009294039ns5:RetainedEarningsAccumulatedLosses2016-11-3009294039ns5:FurnitureFittings2016-12-012017-11-3009294039ns5:ComputerEquipment2016-12-012017-11-3009294039ns5:FurnitureFittings2016-11-3009294039ns5:ComputerEquipment2016-11-3009294039ns5:FurnitureFittings2017-11-3009294039ns5:ComputerEquipment2017-11-3009294039ns5:FurnitureFittings2016-11-3009294039ns5:ComputerEquipment2016-11-3009294039ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-11-3009294039ns5:CurrentFinancialInstrumentsns5:WithinOneYear2016-11-3009294039ns10:OrdinaryShareClass12017-11-30


REGISTERED NUMBER: 09294039 (England and Wales)






















Unaudited Financial Statements

for the Year Ended 30 November 2017

for

Nutrapharma Limited

Nutrapharma Limited (Registered number: 09294039)






Contents of the Financial Statements
for the Year Ended 30 November 2017




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Nutrapharma Limited

Company Information
for the Year Ended 30 November 2017







DIRECTOR: E Hilton





REGISTERED OFFICE: 15 Newland
Lincoln
Lincolnshire
LN1 1XG





REGISTERED NUMBER: 09294039 (England and Wales)






Nutrapharma Limited (Registered number: 09294039)

Balance Sheet
30 November 2017

2017 2016
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 3 8,053 2,279

CURRENT ASSETS
Debtors 4 - 8,487

CREDITORS
Amounts falling due within one year 5 7,723 5,708
NET CURRENT (LIABILITIES)/ASSETS (7,723 ) 2,779
TOTAL ASSETS LESS CURRENT
LIABILITIES

330

5,058

CAPITAL AND RESERVES
Called up share capital 6 100 100
Retained earnings 230 4,958
SHAREHOLDERS' FUNDS 330 5,058

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2017.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2017 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end
of each financial year and of its profit or loss for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director on 13 November 2018 and were signed by:





E Hilton - Director


Nutrapharma Limited (Registered number: 09294039)

Notes to the Financial Statements
for the Year Ended 30 November 2017

1. STATUTORY INFORMATION

Nutrapharma Limited is a private company, limited by shares , registered in England and Wales. The company's
registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

First year adoption of Financial Reporting Standard 102 ( FRS 102) Section 1A

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,
value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on reducing balance
Computer equipment - 33% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to
the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the
balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws
that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal
of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the
lease.

Nutrapharma Limited (Registered number: 09294039)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2017

3. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 December 2016 1,534 1,497 3,031
Additions 5,232 1,728 6,960
At 30 November 2017 6,766 3,225 9,991
DEPRECIATION
At 1 December 2016 361 391 752
Charge for year 611 575 1,186
At 30 November 2017 972 966 1,938
NET BOOK VALUE
At 30 November 2017 5,794 2,259 8,053
At 30 November 2016 1,173 1,106 2,279

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2017 2016
£    £   
Other debtors - 8,487

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2017 2016
£    £   
Taxation and social security 1,992 4,329
Other creditors 5,731 1,379
7,723 5,708

6. CALLED UP SHARE CAPITAL


Allotted, issued and fully paid:
Number: Class: Nominal 2017 2016
value: £    £   
100 Ordinary £1 100 100

7. FIRST YEAR ADOPTION

No transitional adjustments arose on the transition to FRS102.